The authors are reporting on a study drawn from unpublished dissertation done by the corresponding author when he completed his neurosurgical training in Paris, France in 2004, few years before the advent of flow diverters. The study was a retrospective review of giant intracranial aneurysms treated by superficial temporal artery to middle cerebral artery bypass combined with endovascular occlusion of the parent artery. From 1990 to 2003, 29 consecutive cases of giant cerebral aneurysms, not suitable to selective treatment were managed in that way. Twenty-one medical records had enough data to allow objective evaluation. Sixteen female and five male patients bearing 21 giant aneurysms were involved. Their mean age was 46 years. The aneurysm was revealed by mass effect in 13 cases and subarachnoid hemorrhage in one case. On admission 19 patients presented with unruptured aneurysms and two have sustained a subarachnoid hemorrhage. The balloon occlusion test before the bypass operation was not tolerated in 18 patients. The treatment was completed in 19 patients and 17 of them had parent artery occlusion with latex detachable balloons. The only death of the series occurred before the endovascular treatment. The mean follow-up period was 30 months. After completion of the treatment, 16 (84%) patients had no symptom. Aneurysm recanalization or rupture was not observed after the parent artery occlusion. With the combination of superficial temporal artery to middle cerebral artery bypass + endovascular parent artery occlusion, 90% of giant intracranial aneurysms untreatable selectively were permanently excluded with a good outcome in 95%.
Introduction
. It sounds that FD might become the gold standard for treating complex IAs in the very near future but, flow diversion is not without risks and is far from definitely answering the complex problem presented by the management of complex IAs [5] . Therefore, all treatment modalities remain on the table. Giant intracranial aneurysms are arbitrary defined as those having a size ≥ 25 millimeters. The natural history of GIAs is dismal because the reported mortality can be as high as 100% at 2 years after the diagnosis and because neurological morbidity is high in the survivors [5] [6] [7] . The treatment of these lesions is challenging both for neurosurgeons and interventional neuroradiologists. A significant number of GIAs is not suitable neither for direct surgical clipping nor selective embolization, and a vast majority of those which were occluded by embolization at 100% will recanalize [8] . The coil-embolization often necessitates many procedures with significant procedure related morbidity [9] .
In spite of the advent of new endovascular devices such as the balloon assisted technique, stenting, or trispan coils, the optimal treatment of GIAs is not yet defined [5] [9] . Since the introduction of flow diverters such as the Pipeline embolization device (PED) and the SILKstent device in clinical practice, the endovascular management of complex IAs has been tremendously simplified. Nevertheless, the U.S. Food and Drug Administration approval for PED was restricted to unruptured large and GIAs from the internal carotid artery between the superior hypophyseal and cavernous segments [1] (Table 1) . After the PAO intervention and discharge from the hospital, patients were followed up in an out-patient setting on regular basis. The clinical outcome was determined at three, six and 12 months after treatment and at the last follow up visit with the modified Rankin scale (mRS) ( Table 2 ). The mRS was rated using structured interviews. The cut-off point between good and poor outcomes was ≤2.
The Bypass Operation
A standard STA-MCA bypass [12] [13] was performed in 20 patients (one failure due to an atheromatous superficial temporal artery), and an OA-MCA bypass in one. At day-1 after surgery, patients were started on Aspirin 250 mg/day and Persantine 250 mg TID. A Transcranial Doppler (TCD) was done around day-5 to assess the patency of the anastomosis. Then, the patient was transferred to the interventional neuroradiology unit one week after the bypass to undergo a second BOT and a subsequent PAO. All the clinical events thought to be related to the bypass intervention were recorded.
The BOT and PAO
Before the STA-MCA bypass, the BOT was not tolerated in 18 patients and 3 patients had a functionally insufficient circle of Willis. The BOT was done under was performed until it reached the internal carotid artery which was planned to be occluded. The test was done with the patient under intravenous heparin infusion. The criteria for tolerance were as follows:
• No change in the neurological status for 30 minutes;
• Cerebral perfusion time and venous phase appearance delayed no more than 1 second on the side of the occlusion compared to the opposite site; • No change in clinical status or cerebral perfusion when hypotension was induced.
After the STA-MCA bypass surgery, the BOT became well tolerated in 18 patients but remained not tolerated in 3. One of these 3 patients underwent PAO.
The mean duration between the STA-MCA bypass and PAO was 14 days (range:
6 -30). The endovascular procedure done was PAO with latex detachable balloons in 17 cases and with GDC in one case. One patient had partial embolization (70%) of his aneurysm, another patient could not be treated as she refused the saphenous vein bypass graft, and one patient died before endovascular treatment. After the endovascular treatment, patients were admitted to the neurosurgical intensive care unit for 48 hours with complete bed rest. Patients were then followed up clinically and with serial skull x-rays to verify that the balloons remained inflated. Post-procedure CT scans, MRIs, and DSAs were done at 1 week, 6 months, and then once a year to document disappearance of the aneurysm. Table 3 summarizes the clinical and radiological features of the series. In total, 29 patients with GIAs have been treated by this approach during the study period. Nevertheless, only 21 medical records had enough data to allow objective evaluation. These comprised 16 female and 5 male patients bearing 21 GIA. Their mean age was 46 years. Mass effect revealed the aneurysm in 13 cases while SAH did so in 1 case. On admission, 19 patients had unruptured aneurysms and the two who ruptured their aneurysm were grade I at the WFNS scale ( Table 1 In cases n˚ 7 and 11, the BOT was still not tolerated disclosing an asynchronous filling both in the arterial and venous phases for patient 11, and aphasia for patient 7 despite patent STA-MCA bypasses. Maybe those two patients could benefit more from a high-flow bypass.
Results

Clinical and Radiologic Data
On the other hand, cases n˚ 9 and 14 had an assumed well tolerated BOT, but patient 9 finally had minimal permanent deficit (mRS score 1), while patient 14 completely recover from his right arm weakness. Nevertheless, the mechanism underlying the decrease in visual acuity of case n° 7 was not clear. The follow-up
MRIs and angiographies showed complete obliteration of the aneurysm in all patients treated by PAO. We observed neither recanalization nor rupture after PAO.
The BOT
After the STA-MCA bypass, the BOT was still not tolerated in 3 cases. One could not be treated as she refused the saphenous vein grafting proposed to her, another patient had partial embolization (70%) of the aneurysm with no subsequent incident to date, and the other patient (N˚ 11) underwent PAO with poor outcome.
Concerning the 18 patients who had a well-tolerated BOT, two of them (N˚ 9 and 14) presented complications after PAO. The outcome was finally good for 
Outcome
The Figure 1 shows the clinical outcome as determined by the modified RS. The 
Discussion
The dismal natural history of GIAs does not permit to consider treatment abstention as option unless the general status of the patient does not allow any invasive procedure [6] [5] . Some authors [9] [14] had suggested that PAO could be the treatment of choice for GIAs because selective embolization is not often curative. In the series from Ross [9] , among 10 patients who were treated with selective embolization, only one patient was cured, after spontaneous occlusion of the parent artery following embolization.
Conversely, the 9 cases treated by PAO were all cured. In the series of Hans
Henkes [8] , PAO achieved the highest rate of total or near total obliteration of the aneurysm (90% -100%) while the morbidity related to that procedure was among the lowest. Furthermore, the recanalization rate after coil embolization of large and giant aneurysms in that series was as high as 90%. In our point of view, selective treatment with preservation of afferent and efferent vessels should remain the first treatment whenever possible. Keen, cited by Cloft was the first to treat an intracranial aneurysm by hunterian ligation of the internal carotid artery [6] . Subsequently, selective surgical and endovascular treatment had proved su- [24] .
That was the debate before the introduction of flow diverters to clinical practice. Today, it is clear that FD is the first choice option while dealing with complex IAs and hence, GIAs. It was amazing for us to compare FD which has brought a new paradigm for managing GIAs, to this endovascular PAO series.
The result was surprising and not so in favor of FD. As one can see in Table 4 , FD was not superior to PAO in terms of technical feasibility, complete aneurysmal A. Ndoumbe, A. Redondo occlusion rates, procedure-related mortality and morbidity and good outcomes. 
Conclusion
The advent of flow diversion has revolutionized the treatment of complex intracranial aneurysms in general and GIAs in particular. In the very near future, flow-diversion will probably become the first treatment option for the management of complex IAs. It is obvious that most GIAs of this series would have been successfully treated with FD. In this series, 90% of GIAs are not suitable for selective methods could be definitely treated by STA-MCA bypass combined to endovascular PAO and achieving a good neurological outcome (mRS 0 -1) in 95% of the patients. Moreover, the results from this "old series and treatment modality" are comparable to the most recent flow-diversion series in terms of technical feasibility, complete aneurysmal occlusion rates, procedure-related mortality and morbidity and favorable outcomes. Since the optimal treatment of
GIAs is yet to be defined, endovascular PAO with or without a previous EC-IC bypass might still be the best option for any single patient with a GIA.
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